Provided by Tiger Trade Technology Pte. Ltd.

Sunshine Biopharma Inc.

0.4300
-0.2700-38.57%
Pre-market: 0.3854-0.0446-10.37%07:01 EDT
Volume:118.47M
Turnover:95.30M
Market Cap:1.85M
PE:-0.04
High:0.4708
Open:0.4708
Low:0.3802
Close:0.7000
52wk High:24.30
52wk Low:0.3564
Shares:4.31M
Float Shares:4.04M
Volume Ratio:3.20
T/O Rate:2931.03%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-10.0329
EPS(LYR):-14.3739
ROE:-21.92%
ROA:-9.91%
PB:0.07
PE(LYR):-0.03

Loading ...

Sunshine Biopharma Cuts Exercise Price of Outstanding Series B Warrants to $1.22

Reuters
·
Aug 03

Sunshine Biopharma Receives Health Canada Approval for Generic Ondansetron to Treat Chemotherapy-Induced Nausea

MT Newswires Live
·
Jul 28

Sunshine Biopharma announces approval of generic Ondansetron tablets

TIPRANKS
·
Jul 28

Sunshine Biopharma - Enters At-the-market Sales Agreement with Aegis Capital for up to $4 Mln - SEC Filing

THOMSON REUTERS
·
Jul 21

Sunshine Biopharma Plans up to $4 Million At-the-market Share Sale Via Aegis Capital

Reuters
·
Jul 21

Sunshine Biopharma announces publication of new results on MR1-114

TIPRANKS
·
Jul 20

Sunshine Biopharma Says Study Shows Mr1-114 Sars-cov-2 Inhibitor Effective in Mice, Potent in Vitro Across Variants

Reuters
·
Jul 20

Sunshine Biopharma Announces Release of Research Findings Press Statement

Reuters
·
Jul 20

Sunshine Biopharma Settles Dispute with Former Nora Pharma President for CAD 1.5 Million

Reuters
·
Jul 11

Sunshine Biopharma Wins Canadian Approval for Generic Arimidex Tablet

Reuters
·
Jun 25

Sunshine Biopharma shareholders OK Nasdaq-related approval provisions for Series C warrants from $6 million offering

Reuters
·
Jun 09

Sunshine Biopharma wins Canadian approval for generic Xarelto drug rivaroxaban tablets

Reuters
·
Jun 01

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 03:58 AM

Reuters
·
Jun 01

NASDAQ TRADE HALT HALT NEWS PENDING AT 03:28 AM

Reuters
·
May 30

Sunshine Biopharma Inc trading halted, news pending

TIPRANKS
·
May 30

Sunshine Biopharma shareholder approved discounted share issuance above 20% Nasdaq limit

Reuters
·
May 30

Sunshine Biopharma files draft information statement on warrant approval provisions

Reuters
·
May 30

Sunshine Biopharma wins US patent for coronavirus treatment technology

Reuters
·
May 29

Sunshine Biopharma executes 1-for-10 reverse stock split effective June 1 to maintain Nasdaq listing

Reuters
·
May 28

Sunshine Biopharma wins Canadian approval for generic amoxicillin

Reuters
·
May 21